Prism Medico

Market Cap: Micro Cap
Industry: Non Banking Financial Company (NBFC)
ISIN: INE730E01016
NSEID:
BSEID: 512217
View on BSE

INR

24.70

-1.3 (-5.0%)

BSENSE

Mar 05

BSE+NSE Vol: 38.13 k

Access older stock analysis version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Prism Medico

Shyamkamal Inv

Bazel Internatio

Decillion Financ

Rita Finance and

DJS Stock

Bharat Bhushan

Amrapali Fincap

HB Leasing &Fin.

Golden Legand Ls

J J Finance Corp

Why is Prism Medico & Pharmacy Ltd ?

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0
The company has been able to generate a Return on Equity (avg) of 0.59% signifying low profitability per unit of shareholders funds

Flat results in Dec 25

NO KEY NEGATIVE TRIGGERS

With ROE of 4, it has a Expensive valuation with a 1 Price to Book Value

The stock is trading at a discount compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 57.32%, its profits have risen by 77% ; the PEG ratio of the company is 0.1

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Non Banking Financial Company (NBFC))

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Prism Medico for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Prism Medico

57.32%

0.99

57.80%

Sensex

8.53%

0.73

11.73%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-33.56%

EBIT Growth (5y)

1.55%

EBIT to Interest (avg)

Debt to EBITDA (avg)

1.90

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.65

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

-2.23%

ROE (avg)

0.59%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.99

EV to EBIT

14.91

EV to EBITDA

14.91

EV to Capital Employed

0.99

EV to Sales

6.68

PEG Ratio

0.05

Dividend Yield

ROCE (Latest)

-0.53%

ROE (Latest)

4.04%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bearish

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

PAT(9M)

Higher at Rs 0.57 Cr

-1What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Loading Valuation Snapshot...

Here's what is working for Prism Medico

Profit After Tax (PAT) - Nine Monthly

Higher at Rs 0.57 Cr

than preceding 12 month period ended Dec 2025 of Rs -0.05 cr

MOJO Watch

In the nine month period the company has already crossed sales of the previous twelve months

PAT (Rs Cr)